Sana Biotechnology Inc vs TransMedics Group Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: TransMedics Group Inc is far larger — about 2.9× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| SANA | TMDX | |
|---|---|---|
Market Cap | $873.84M | $2.54B |
Sector | Health | Technology |
52-Week High | $5.92 | $150.42 |
52-Week Low | $2.68 | $61.99 |
Enterprise Value | $848.03M | $2.94B |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →